Delgocitinib Effective for Hand Eczema in Phase 3 Studies
Topical delgocitinib, a pan-Janus kinase inhibitor, showed promise in treating moderate to…
Delgocitinib Effective for Hand Eczema in Phase 3 Studies
Topical delgocitinib, a pan-Janus kinase inhibitor, was found to be well tolerated…
New Treatment For Male Pattern Baldness? Study Identifies Body Sugar That Holds Key
Researchers from the University of Sheffield and COMSATS University Pakistan have discovered…
Earning Trust in Neurotech – MedCity News
This year saw significant advancements in neurotech, with companies like Neuralink conducting…
Vision Van aims to drive down cases of preventable blindness
Vision Ireland has launched a new initiative called the Vision Van to…
California Forges Ahead With Social Media Rules Despite Legal Barriers
California lawmakers are working on legislation to protect children from the negative…
Occupational benzene exposure heightens lung cancer likelihood
A study published in the American Journal of Respiratory and Critical Care…
Biotech launches with $165 million for cancer, autoimmune therapies
In 2021, Sanjaya Singh, known for his contributions in immunology and oncology,…
Deprescribing makes me weep | The BMJ
A retired GP and senior research fellow in Leeds, UK, Arnold Zermansky…
New findings shed light on risks and benefits of integrating AI into medical decision-making
The study conducted by researchers at the National Institutes of Health found…